Arbutus Biopharma (ABUS) Assets (2010 - 2026)
Arbutus Biopharma's Assets came in at $274.03 million for Q2 2026, up 165.4% from $103.27 million a year earlier but down 1.1% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma's Assets was $94.62 million, down 28.2% from FY2024.
- Assets has declined in each of the last four years, with a five-year compound annual growth rate of -7.1% (FY2020 to FY2025).
- Going back by year, Assets was $131.71 million in FY2024 (-8.8%), $144.4 million in FY2023 (-26.1%), $195.42 million in FY2022 (-4.4%) and $204.49 million in FY2021 (+49.2%).
- The five-year range for quarterly Assets is $94.62 million (Q4 2025) to $277.16 million (Q1 2026).
- Year-over-year, Assets increased in two of the last eight quarters, with growth averaging 20.7%.
- The fastest year-over-year change in Assets over five years came in Q2 2026 (growth of 165.4%), and the weakest in Q2 2025 (a decline of 35.5%).
- Business Quant data shows ABUS's Assets at $277.16 million (Q1 2026), $94.62 million (Q4 2025) and $97.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | 274.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 274.03 Mn |
| Mar 31, 2026 | 277.16 Mn |
| Dec 31, 2025 | 94.62 Mn |
| Sep 30, 2025 | 97.71 Mn |
| Jun 30, 2025 | 103.27 Mn |
| Mar 31, 2025 | 117.01 Mn |
| Dec 31, 2024 | 131.71 Mn |
| Sep 30, 2024 | 140.44 Mn |
| Jun 30, 2024 | 160.04 Mn |
| Mar 31, 2024 | 150.29 Mn |
| Dec 31, 2023 | 144.40 Mn |
| Sep 30, 2023 | 158.64 Mn |
| Jun 30, 2023 | 176.82 Mn |
| Mar 31, 2023 | 191.22 Mn |
| Dec 31, 2022 | 195.42 Mn |
| Sep 30, 2022 | 203.80 Mn |
| Jun 30, 2022 | 215.84 Mn |
| Mar 31, 2022 | 236.88 Mn |
| Dec 31, 2021 | 204.49 Mn |
| Sep 30, 2021 | 165.60 Mn |
API Access
Arbutus Biopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();